You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
22 December 2010
Merrion Pharmaceuticals Plc Signs Collaboration and Option Agreement and Warrant Agreement With Novo Nordisk
6 December 2010
Merrion Pharmaceuticals Plc Signs Feasibility and Option Agreement for 3 Drugs With International ‘Top Ten’ Pharmaceutical Company
23 November 2010
Merrion Pharmaceuticals Plc Announces Commencement of Feasibility and Option Agreement With Rebel Pharmaceuticals
16 November 2010
Merrion Finalises Its Phase III Development Program for Orazol(TM) in the USA
7 May 2010
Merrion Pharmaceuticals is Issued a Key U.S. Patent for Orazol(TM), Their Lead Product to Treat Bone Metastases Associated With Prostate, Breast and Other Cancers
4 March 2010
Merrion Pharmaceuticals erhaelt US-Schluesselpatent
Merrion Pharmaceuticals erhält US-Schlüsselpatent
2 March 2010
Merrion Pharmaceuticals is Issued a Key United States Patent
7 December 2009
Novo Nordisk Starts Phase 1 Trial With Oral Insulin Analogue — Merrion Pharmaceuticals Earns USD 2 Million Milestone Payment
20 May 2009
Merrion Pharmaceuticals Plc gibt erste Ergebnisse der Phase II Orazol(tm) Studie bekannt
15 May 2009
Merrion Pharmaceuticals Plc Announces Preliminary Results On Phase II Orazol(tm) Study
